These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7923752)

  • 1. Guidelines for routine liver biopsy during methotrexate treatment.
    Cash JM; Wilke WS
    Cleve Clin J Med; 1994; 61(4):317-8. PubMed ID: 7923752
    [No Abstract]   [Full Text] [Related]  

  • 2. [Liver damage in methotrexate-treated patients. When liver biopsy is necessary in the follow-up?].
    Nieminen U; Höök-Nikanne J; Kärkkäinen P; Niemelä S
    Duodecim; 2005; 121(24):2680-8. PubMed ID: 16454249
    [No Abstract]   [Full Text] [Related]  

  • 3. Massive intrahepatic hemorrhage following routine liver biopsy in a patient with rheumatoid arthritis treated with methotrexate.
    Cash JM; Swain M; Di Bisceglie AM; Wilder RL; Crofford LJ
    J Rheumatol; 1992 Sep; 19(9):1466-8. PubMed ID: 1433018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis.
    Szanto E; Sandstedt B; Kollberg B
    Scand J Rheumatol; 1987; 16(4):229-34. PubMed ID: 3629206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going?
    Kremer JM
    J Rheumatol; 1992 Feb; 19(2):189-91. PubMed ID: 1629814
    [No Abstract]   [Full Text] [Related]  

  • 6. Longterm methotrexate therapy in rheumatoid arthritis: a review.
    Kremer JM
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB; Arnold GL; Gowans JD; Kaplan MM
    Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology.
    Kremer JM; Alarcón GS; Lightfoot RW; Willkens RF; Furst DE; Williams HJ; Dent PB; Weinblatt ME
    Arthritis Rheum; 1994 Mar; 37(3):316-28. PubMed ID: 8129787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate therapy in rheumatoid arthritis: 15 years experience.
    Hoffmeister RT
    Am J Med; 1983 Dec; 75(6A):69-73. PubMed ID: 6660241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creating a care-effective cost-effective strategy for methotrexate liver toxicity monitoring in rheumatoid arthritis: comment on the article by Kremer et al.
    Newman ED; Harrington TM; Perruquet JL; Davis DE; Torretti D
    Arthritis Rheum; 1995 Feb; 38(2):297-8. PubMed ID: 7848325
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
    Phillips CA; Cera PJ; Mangan TF; Newman ED
    J Rheumatol; 1992 Feb; 19(2):229-33. PubMed ID: 1629819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate and the liver.
    Tolman KG; Clegg DO; Lee RG; Ward JR
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():29-34. PubMed ID: 3831362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis.
    Mackenzie AH
    Cleve Clin Q; 1985; 52(2):129-35. PubMed ID: 4028418
    [No Abstract]   [Full Text] [Related]  

  • 14. Monitoring patients taking methotrexate for hepatotoxicity. Does the standard of care match published guidelines?
    Petrazzuoli M; Rothe MJ; Grin-Jorgensen C; Ramsey WH; Grant-Kels JM
    J Am Acad Dermatol; 1994 Dec; 31(6):969-77. PubMed ID: 7962779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients.
    Erickson AR; Reddy V; Vogelgesang SA; West SG
    Arthritis Rheum; 1995 Aug; 38(8):1115-9. PubMed ID: 7639808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring for methotrexate hepatotoxicity in patients with rheumatoid arthritis: another hepatologist's perspective.
    Lewis JH
    J Rheumatol; 1997 Aug; 24(8):1459-60. PubMed ID: 9263133
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver biopsy in methotrexate treatment.
    Zachariae H; Schiodt T
    Acta Derm Venereol; 1971; 51(3):215-20. PubMed ID: 4103033
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate-induced hepatic necrosis requiring liver transplantation in a patient with rheumatoid arthritis.
    Hakim NS; Kobienia B; Benedetti E; Bloomer J; Payne WD
    Int Surg; 1998; 83(3):224-5. PubMed ID: 9870779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Palmer HM
    Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities.
    Yazici Y; Erkan D; Harrison MJ; Nikolov NP; Paget SA
    Clin Exp Rheumatol; 2005; 23(4):517-20. PubMed ID: 16095122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.